Prescription migraine medicine

As per available reports about  55 journals, 46 Conferences, 68 workshops are presently dedicated exclusively to migraine and about  158 articles are being published on the current trends in migraine. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. Migraine is a long-lasting neurological disorder categorized by repeated moderate to stark headaches often in association with a number of autonomic nervous system symptoms.  Classically the headache affects one half of the head, is effervescent in nature, and lasts from 2 to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is usually made poorer by physical movement.

The Journal of Brain Disorders & Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in migraine. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Brain Disorders & Therapy provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of migraine and bioinformatics, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences. OMICS Group conferences in the field of Omics will offer much exciting scientific research presented in the lectures, posters, workshops and symposia by various academic and industrial organizations. All the accepted abstracts will be published in the respective OMICS Group Omics Journals, which are Open Access.